About a quarter of patients (26.3%) had at least two co-morbidities. Moxifloxacin therapy was started within a week of the appearance of acute symptoms in most patients (83.5%); the mean interval ...

The activity, pharmacokinetics, pharmacodynamics, efficacy, safety, drug interactions, and dosage and administration of moxifloxacin are reviewed. Moxifloxacin is an oral 8-methoxyquinolone ...

Moxifloxacin (as HCl) 400mg/250mL; soln for IV infusion; latex- and preservative-free. Moxifloxacin inhibits topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial ...

Discover all the brand names or Trade names of generic drug called Moxifloxacin. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

The BPaLM regimen, which consists of a four-drug combination—Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin—has been ...

Table 1 TB drug candidates in clinical development Full size table The two furthest advanced of the seven clinical candidates are the 8-methoxy-fluoroquinolones gatifloxacin and moxifloxacin (see ...

The union government has approved a shorter and more effective treatment regimen for multi-drug-resistant tuberculosis. This ...

THE Union Health Ministry has approved the introduction of the BPaLM regimen, a novel treatment for multi-drug resistant ...

moxifloxacin, norfloxacin or ofloxacin Antidepressants such as citalopram, fluoxetine, fluvoxamine, venlafaxine, paroxetine ...

The Centre has approved the introduction of BPaLM regimen for more effective and a quicker treatment option for ...

Move expected to significantly boost progress towards the national goal of Ending TB in India ...